Delayed booster dosing improves human antigen-specific Ig and B

medRxiv - The Preprint Server for Health Sciences

Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Antibodies, Free Full-Text

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine

Frontiers Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost

Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses - ScienceDirect

B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity

JCI Insight - Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Frontiers Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

Two complementary features of humoral immune memory confer protection against the same or variant antigens